Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02306122 · ClinicalTrials.gov registry record · NA
Pharmacy Home Adherence Reporting and Monitoring Outcomes Study
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 2,697
- Enrollment target
NCT02306122 is a NA study that has completed, run by Brown University. The registered enrollment target is 2,697 participants.
The verdict
NCT02306122, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,697 participants
- Enrollment target
Study Summary
This study is a pilot test of an intervention that delivers timely diagnostic information about medication nonadherence to doctors, and then offers the services of clinical pharmacists to treat these nonadherence problems. Participating doctors will be notified when a patient is 10 days late refilling a medication for diabetes, hypertension, or hypercholesterolemia. In one randomization arm the pharmacist will contact the patient as the default option (with no action required by the doctor), and in the other the pharmacist will contact the patient only if the doctor actively chooses that the pharmacist take action. Patients of participating doctors will be randomized to 1) one of these two pharmacist options, 2) an information only control arm in which the doctor gets adherence information but does not have access to a pharmacist for that patient, and 3) a no information control arm. The investigators' central hypothesis is that the pharmacist will be consulted more often when intervention by the pharmacist is the default outcome and that the default pharmacist intervention will be the most beneficial for adherence outcomes.
Interventions
- BEHAVIORAL Pharmacist calls patient unless physician cancels call
- BEHAVIORAL Patient nonadherence information sent to physician
- BEHAVIORAL Pharmacist calls patient if physician requests call
- BEHAVIORAL Doctor receives information and may be allowed certain actions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,697 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02306122
The ClinicalTrials.gov registry entry for NCT02306122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,697 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Pharmacist calls patient unless physician cancels call is the first listed.
NCT02306122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02306122 about?
NCT02306122 is a clinical study titled "Pharmacy Home Adherence Reporting and Monitoring Outcomes Study". This study is a pilot test of an intervention that delivers timely diagnostic information about medication nonadherence to doctors, and then offers the services of clinical pharmacists to treat these nonadherence problems. Participating doctors will be notified when a patient is 10 days late refilli...
What is the current status of trial NCT02306122?
This trial is currently completed. It is a NA study. The enrollment target is 2,697 participants. The study started on 2011-03. Estimated completion is 2014-02.
What interventions are being tested in trial NCT02306122?
The interventions under investigation include: Pharmacist calls patient unless physician cancels call (BEHAVIORAL), Patient nonadherence information sent to physician (BEHAVIORAL), Pharmacist calls patient if physician requests call (BEHAVIORAL), Doctor receives information and may be allowed certain actions (BEHAVIORAL).
Who is sponsoring clinical trial NCT02306122?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.